Ma, Juan <br/><br/>
Bispecific anti-CD3 x anti-B7-H3 antibody mediates T cell cytotoxic ability to human melanoma in vitro and in vivo.  [electronic resource] 

 -  Investigational new drugs  10 2019 
 - 1036-1043 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-0646 
<br/><br/><label>Standard No.: </label>10.1007/s10637-018-00719-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Bispecific--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis<br/>B7 Antigens--antagonists & inhibitors<br/>CD3 Complex--antagonists & inhibitors<br/>Cell Proliferation<br/>Humans<br/>In Vitro Techniques<br/>Lymphocyte Activation<br/>Melanoma--drug therapy<br/>Mice<br/>Mice, SCID<br/>T-Lymphocytes--immunology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays